Ancora Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.2K | Buy |
237
+25
| +12% | +$9.72K | ﹤0.01% | 880 |
|
|
2025
Q1 | $92.2K | Buy |
212
+2
| +1% | +$870 | ﹤0.01% | 864 |
|
|
2024
Q4 | $77.5K | Buy |
210
+9
| +4% | +$3.32K | ﹤0.01% | 892 |
|
|
2024
Q3 | $105K | Buy |
201
+2
| +1% | +$1.04K | ﹤0.01% | 798 |
|
|
2024
Q2 | $108K | Hold |
199
| – | – | ﹤0.01% | 764 |
|
|
2024
Q1 | $103K | Hold |
199
| – | – | ﹤0.01% | 784 |
|
|
2023
Q4 | $93.8K | Hold |
199
| – | – | ﹤0.01% | 781 |
|
|
2023
Q3 | $86.6K | Hold |
199
| – | – | ﹤0.01% | 783 |
|
|
2023
Q2 | $88.4K | Hold |
199
| – | – | ﹤0.01% | 776 |
|
|
2023
Q1 | $91.5K | Sell |
199
-3
| -1% | -$1.38K | ﹤0.01% | 764 |
|
|
2022
Q4 | $104K | Buy |
202
+46
| +29% | +$23.7K | ﹤0.01% | 793 |
|
|
2022
Q3 | $71K | Sell |
156
-5
| -3% | -$2.28K | ﹤0.01% | 958 |
|
|
2022
Q2 | $78K | Buy |
161
+45
| +39% | +$21.8K | ﹤0.01% | 1012 |
|
|
2022
Q1 | $57K | Buy |
116
+13
| +13% | +$6.39K | ﹤0.01% | 1167 |
|
|
2021
Q4 | $48K | Hold |
103
| – | – | ﹤0.01% | 1291 |
|
|
2021
Q3 | $38K | Hold |
103
| – | – | ﹤0.01% | 1258 |
|
|
2021
Q2 | $39K | Sell |
103
-4
| -4% | -$1.52K | ﹤0.01% | 1151 |
|
|
2021
Q1 | $38K | Buy |
107
+4
| +4% | +$1.42K | ﹤0.01% | 1124 |
|
|
2020
Q4 | $33K | Sell |
103
-6
| -6% | -$1.92K | ﹤0.01% | 949 |
|
|
2020
Q3 | $29K | Buy |
109
+36
| +49% | +$9.58K | ﹤0.01% | 920 |
|
|
2020
Q2 | $19K | Hold |
73
| – | – | ﹤0.01% | 967 |
|
|
2020
Q1 | $17K | Hold |
73
| – | – | ﹤0.01% | 1039 |
|
|
2019
Q4 | $22K | Buy |
+73
| New | +$22K | ﹤0.01% | 1026 |
|
|
2018
Q4 | – | Sell |
-102
| Closed | -$28K | – | 771 |
|
|
2018
Q3 | $28K | Buy |
+102
| New | +$28K | ﹤0.01% | 1009 |
|